Check out our latest paper discussing an impedance sensor for early detection of gastrointestinal anastomotic leaks.
Shout out to the authors @matan_bendavid_ Ran Orgad, Idan Carmeli, @YeredTal, Bar Nathansohn-Levi @ErezShor Nir Wasserberg
https://t.co/vu39nAl0QX
https://t.co/lRqn7VgOYv
t���s days like this that make it all worth it. The first #GI surgical patient in our new clinical trial has been implanted with our xBar sensor and the system is already monitoring the tissue healing process and analyzing the data from the surgical site.
Excited to share a grand slam today!
Exero has raised an impressive SAFE, getting ready for
our upcoming clinical trial.
Special thanks to @CBG for leading the SAFE and WELCOME to our new VPs Ilana Fishman and @LermanGilad .
Happy holidays everyone!
https://t.co/dTMRjs7Vc9
Excited to share a grand slam today!
Exero has raised an impressive SAFE, getting ready for
our upcoming clinical trial.
Special thanks to @CBG for leading the SAFE and WELCOME to our new VPs Ilana Fishman and @LermanGilad .
Happy holidays everyone!
https://t.co/dTMRjs7Vc9
Excited to share our preclinical and clinical study results at #sages2021. The clinical study was led by Prof. Nir Wasserberg in collaboration with Profs. @profcknowles Gareth Sanger and @matan_bendavid_
https://t.co/1NDjlqU433
We are excited to announce that Dr. Deborah Nagle, Chief of the Colon and Rectal Division of Renaissance School of Medicine at Stony Brook University, will be joining Exero Medical as a member of our scientific advisory board. https://t.co/0GJZ3l92mE #medtech#colorectalsurgery
The FDA has granted Exero Medical breakthrough designation status, a label reserved for #MedicalDevices with the potential to provide more effective treatment or diagnosis of potentially life-threatening conditions or diseases. @Jerusalem_Post https://t.co/Wye7QcVtoT #MedTech
We have been granted #FDA Breakthrough Device Designation for our #smartsensor technology! We look forward to working closely with FDA regulators to achieve full clearance of our system to provide #earlydetection of #GI leaks. https://t.co/iD7rjcqN2m #GITwitter
We recently completed the first human implantation of our sensor for early detection of anastomotic leaks following gastrointestinal surgery. Learn more about the procedure and how our #earlydetection system can help save lives. https://t.co/uo7bLUcDmv
We are pleased to share that we have completed the first human implantation of our sensor, a significant milestone as we work towards developing a reliable anastomotic leak #earlydetection system. Read more: https://t.co/BsN0l5HC4x #GItwitter#medtech
Exero Medical is pleased to announce our first #clinicaltrial will be taking place at Rabin Medical Center! Researchers will use our wireless sensor for #earlydetection of anastomotic leaks to collect data during #GI surgery. https://t.co/xzJyqH1uny #GITwitter
Although we couldn't be there in person, we are proud to have shared our “Degradable Biosensor for the Early Detection of Abdominal Sepsis” abstract at the Digestive Disease Week 2020 virtual meeting earlier this week! See it here: https://t.co/CnLrVXGjJZ #DDW2020#GITwitter
Exero Medical is excited to announce that Prof. Charles Knowles, prominent gastrointestinal expert, has been appointed to our scientific advisory board. We are looking forward to providing safer care to #GI surgery patients together! https://t.co/JZsNtrWLK4
Anastomotic leakage is defined as 'a leak of luminal contents from a surgical join' and is the most significant complication to recognize following #gastrointestinal#surgery. Learn more about anastomotic leak, its symptoms and risk factors: https://t.co/Yhx3g5Jyg1 @sciencedirect